Nanotechnology

NanO2 Nanobubble therapeutics program launched

Published in Biotech Business Week, August 8th, 2005

ImaRx Therapeutics, Inc., announced that it has launched its NanO2 Nanobubble Therapeutics program to develop portable emergency oxygen delivery treatments that will enable physicians to treat patients with hemorrhagic shock in the battlefield or other emergency situations.

The program was developed around ImaRx's existing suite of oxygen delivery patents and advanced nanobubble emulsion technologies in addition to four U.S. patents that the company has exclusively sublicensed from Sonus Pharmaceuticals, Inc. The patents cover compositions of matter and methods of using oxygen delivery for treatment of disease.

"ImaRx has strengthened our existing...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2005-08-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry